Cargando…
MicroRNA-375 Targets ATG14 to Inhibit Autophagy and Sensitize Hepatocellular Carcinoma Cells to Sorafenib
PURPOSE: Sorafenib has revolutionized treatment of hepatocellular carcinoma (HCC), but its efficacy is limited by drug resistance. Autophagy is the process by which cellular components are transported to lysosomes for degradation, which promotes energy production and production of macromolecular pre...
Autores principales: | Yang, Shuo, Wang, Minggang, Yang, Liang, Li, Yan, Ma, Yingbo, Peng, Xueqiang, Li, Xinyu, Li, Bowen, Jin, Hongyuan, Li, Hangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197942/ https://www.ncbi.nlm.nih.gov/pubmed/32431510 http://dx.doi.org/10.2147/OTT.S247655 |
Ejemplares similares
-
CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma
por: Li, Bowen, et al.
Publicado: (2021) -
MicroRNA-375 exacerbates knee osteoarthritis through repressing chondrocyte autophagy by targeting ATG2B
por: Li, Hongxing, et al.
Publicado: (2020) -
LINC00511 drives invasive behavior in hepatocellular carcinoma by regulating exosome secretion and invadopodia formation
por: Peng, Xueqiang, et al.
Publicado: (2021) -
PU.1/microRNA-142-3p targets ATG5/ATG16L1 to inactivate autophagy and sensitize hepatocellular carcinoma cells to sorafenib
por: Zhang, Kai, et al.
Publicado: (2018) -
miR-425 regulates lipophagy via SIRT1 to promote sorafenib resistance in liver cancer
por: Sun, Gongping, et al.
Publicado: (2021)